Menu Back to Practical-Guide-for-Pharmacovigilance-Clinical-Trials-and-Post-Marketing

Overview

This is a basic overview course, intended for individuals who have limited experience in pharmacovigilance/drug safety monitoring. The focus will be on pharmacovigilance with traditional medicinal products, both investigational and marketed, intended for human use in clinical trials, in post-marketing studies, and in the healthcare setting following product launch.

Regional developments in the GCC countries will also be highlighted.

Program Committee

  • Gaby L. Danan, MD, PhD
    Gaby L. Danan, MD, PhD Pharmacovigilance Expert
    France
  • William W. Gregory, PhD
    William W. Gregory, PhD Senior Director, Worldwide Safety and Regulatory
    Pfizer Inc, United States
  • Bina S. Patel
    Bina S. Patel Director Case Management Group
    GlaxoSmithKline R&D Ltd., United Kingdom
  • Harri Tapani Helajarvi
    Harri Tapani Helajarvi Former Qualified Person for Pharmacovigilance
    Finland
Load More